NEW YORK—EssilorLuxottica (Euronext: EL) has made moves to restart the European Union’s review process of its proposed acquisition of GrandVision,  (Euronext: GVNV) and the regulatory commission overseeing the review has responded to the actions by setting a new April 12 deadline to rule on the deal. The news was first reported by Bloomberg on Tuesday, and confirmed to VMAIL by a GrandVision spokeswoman. The concessions made by EssilorLuxottica are reported to be a way to “resolve EU’s antitrust concerns.”

“EssilorLuxottica submitted yesterday a remedy package to the European Commission,” the GrandVision spokeswoman said in an email. “This means that the clock has started and the EC deadline to make a decision for the clearance of the jurisdictions is latest April 12.”

She added, “All details of the remedy package are confidential.” EssilorLuxottica officials could not be reached for comment at VMAIL’s presstime Tuesday.

The merger review has been stalled since last summer, when GrandVision and EssilorLuxottica began a series of court filings related to the sharing of information about GrandVision’s retail performance during the pandemic, as VMAIL reported.

In January, however, GrandVision noted in a preliminary report on 2020 sales performance that it remains committed to seeing the proposed $8.8 billion deal through to completion. At that time, GrandVision said the deal already has been unconditionally cleared in the U.S., Colombia, Brazil, and Mexico and it is currently under review in Chile and Turkey. It was approved in Russia, but that clearance has expired.

According to the Bloomberg report, the European Commission set the new April 12 deadline to rule on the deal “after the companies supplied information needed for the review, according to the EU’s press office and its website on Tuesday.”